about
Characterization of the MPS I-H knock-in mouse reveals increased femoral biomechanical integrity with compromised material strength and altered bone geometryCarcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasionMolecular mechanism of type I collagen homotrimer resistance to mammalian collagenases.DNA carrier testing and newborn screening for maple syrup urine disease in Old Order Mennonite communities.Skeletal muscle weakness in osteogenesis imperfecta miceMyostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfectaHindlimb skeletal muscle function in myostatin-deficient mice.Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model.Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related PhenotypeDevelopmental exposure to xenoestrogens at low doses alters femur length and tensile strength in adult mice.Effect of food restriction and leptin supplementation on fetal programming in miceTransplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model.Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta.Transforming growth factor-β1/Smad3-independent epithelial-mesenchymal transition in type I collagen glomerulopathy.Evidence of common ancestry for the maple syrup urine disease (MSUD) Y438N allele in non-Mennonite MSUD patients.The role of type I collagen in aortic wall strength with a homotrimeric.Potential modifier role of the R618Q variant of proalpha2(I)collagen in type I collagen fibrillogenesis: in vitro assembly analysis.Alpha 2(I) collagen deficient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta.Hindlimb Skeletal Muscle Function and Skeletal Quality and Strength in +/G610C Mice With and Without Weight-Bearing Exercise.Live Imaging of Type I Collagen Assembly Dynamics in Osteoblasts Stably Expressing GFP and mCherry-Tagged Collagen Constructs.Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.Structural changes in human type I collagen fibrils investigated by force spectroscopyAscorbic acid and transforming growth factor-beta 1 increase collagen biosynthesis via different mechanisms: coordinate regulation of pro alpha 1(I) and Pro alpha 1(III) collagensImmunological similarity of milk sulfhydryl oxidase and kidney glutathione oxidaseNovel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim)Dietary fluoride restriction does not alter femoral biomechanical strength in col1a2-deficient (oim) mice with type I collagen glomerulopathySkeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis ImperfectaOsteogenesis Imperfecta: Muscle-Bone Interactions when Bi-directionally CompromisedCompromised Exercise Capacity and Mitochondrial Dysfunction in the Osteogenesis Imperfecta Murine (oim) Mouse Model
P50
Q33800106-9F9EA891-591E-490E-90D5-66A20FB00476Q33892014-6E1802A8-75D6-47D9-BCF0-94F988945282Q33991179-B84DD985-C166-4616-ACC5-D8585759CFFCQ34021177-23840B4E-26E1-4862-9A5C-988CB3CA35A7Q34188512-46DDCFA3-43B9-4D14-B6B1-F0FC5AB4C56EQ34485335-5C67DC2E-353C-4266-B87F-C70D1E11FCBCQ34544274-60BE851D-DDC6-4904-B9B7-2D540DB149F5Q34642974-3C1C083D-9B06-4BAE-A452-EBA1BC5A5FBEQ35156234-27C676A6-1158-4CF2-BFDD-E9C7BC3BB3A4Q35790124-009DFEC8-0532-4A13-9A70-34AA8889D5AAQ35862520-814D7C1D-B76F-4603-8D95-6370D5BC37ABQ36177394-FF8DF4D0-5CB8-4903-BF3C-46D1B42863D4Q36206449-8DD1C7D7-A24B-41EE-A20E-53E6FCFFE098Q36989450-18F4AEC5-D258-42EE-87AE-640D8F03A0C7Q41442647-822C50F7-6F40-4244-A848-31A127F6BA6FQ41633919-2D7A9B9D-6BC0-4CBC-9B40-66B354C8444EQ42669161-B53A7A40-13C5-496A-8146-24ADB01D710DQ43628056-797E5FFF-3C72-4E2B-8C64-4DAECF485E68Q44917188-B1217156-963E-4475-B7D1-A6D8908B2A97Q46646460-A173B518-B64F-4092-908C-18AC0DF1E7B1Q47396539-9AB1872B-1D8E-41B2-8CB6-8DC7B84B0FFDQ52692994-AD4BDDDC-D3D2-466F-963B-5B9A0C364012Q52864293-55E65274-CBBA-49C1-8519-E5D669C8602DQ57374051-950C2D69-53B5-4021-B101-41B2BB8E2B3CQ68125746-4DEEDF8F-1B98-4A36-913B-971157A57518Q71268919-650DB600-F402-45D1-93C3-E45953A2B70BQ74443063-FF33B9A6-7F38-4309-8810-23DD4E524443Q84773889-641FC832-4E61-43D5-B73B-9B6F767A313CQ88892608-21902E2E-D29D-42A4-A4AE-1EA6437CDDAEQ89127509-E7650B8C-EC6C-4D05-844D-539D6AABE3B4Q92600055-1D6452E5-C4E2-4843-975C-54CB7BC65BE8
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-7761-3783
@en
name
Charlotte L Phillips
@ast
Charlotte L Phillips
@en
Charlotte L Phillips
@es
Charlotte L Phillips
@nl
type
label
Charlotte L Phillips
@ast
Charlotte L Phillips
@en
Charlotte L Phillips
@es
Charlotte L Phillips
@nl
prefLabel
Charlotte L Phillips
@ast
Charlotte L Phillips
@en
Charlotte L Phillips
@es
Charlotte L Phillips
@nl
P106
P1153
7403136033
P21
P31
P496
0000-0002-7761-3783